NDC 0338-0341

Cardioplegic

Calcium Chloride, Magnesium Chloride, Potassium Chloride And Sodium Chloride

Cardioplegic is a Intra-arterial Solution in the Human Prescription Drug category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is Calcium Chloride; Magnesium Chloride; Potassium Chloride; Sodium Chloride.

• Product ID: 0338-0341_10d0d308-0148-434e-930a-fd27a25e5389
• NDC: 0338-0341
• Product Type: Human Prescription Drug
• Proprietary Name: Cardioplegic
• Generic Name: Calcium Chloride, Magnesium Chloride, Potassium Chloride And Sodium Chloride
• Dosage Form: Solution
• Route of Administration: INTRA-ARTERIAL
• Marketing Start Date: 2000-04-21
• Marketing Category: ANDA / ANDA
• Application Number: ANDA075323
• Labeler Name: Baxter Healthcare Corporation
• Substance Name: CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
• Active Ingredient Strength: 18 mg/100mL; mg/100mL; mg/100mL; mg/100mL
• Pharm Classes: Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0338-0341-04

14 BAG in 1 CARTON (0338-0341-04) > 1000 mL in 1 BAG

• Marketing Start Date: 2000-04-21
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0338-0341-04 [00338034104]

Cardioplegic SOLUTION

• Marketing Category: ANDA
• Application Number: ANDA075323
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2000-04-21

Drug Details

Active Ingredients

Ingredient	Strength
CALCIUM CHLORIDE	17.6 mg/100mL

OpenFDA Data

• SPL SET ID: 1fd50ce5-2799-4c26-81da-02cf0578dd9e
• Manufacturer:
  • Baxter Healthcare Corporation
• UNII:
  • M4I0D6VV5M
  • 02F3473H9O
  • 451W47IQ8X
  • 660YQ98I10

Pharmacological Class

• Blood Coagulation Factor [EPC]
• Increased Coagulation Factor Activity [PE]
• Calcium [CS]
• Cations
• Divalent [CS]
• Calculi Dissolution Agent [EPC]
• Magnesium Ion Exchange Activity [MoA]
• Osmotic Laxative [EPC]
• Osmotic Activity [MoA]
• Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]
• Increased Large Intestinal Motility [PE]
• Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
• Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
• Potassium Compounds [CS]
• Potassium Salt [EPC]
• Osmotic Laxative [EPC]
• Increased Large Intestinal Motility [PE]
• Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
• Osmotic Activity [MoA]
• Osmotic Laxative [EPC]
• Increased Large Intestinal Motility [PE]
• Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
• Osmotic Activity [MoA]